BIMI International Medical Fails to Meet Nasdaq Requirements
April 22, 2023
Trending News 🌧️
BIMI ($NASDAQ:BIMI) International Medical has failed to meet the requirements of the Nasdaq and has been issued a notice of non-compliance. BIMI International Medical is an American multinational medical device company based in California. It is a leading global manufacturer and distributor of medical devices, pharmaceuticals, and consumer health products. In the notice of non-compliance, the Nasdaq stated that BIMI had not met certain criteria related to the listing standards of the exchange.
If these requirements are not met, then BIMI’s common stock will be delisted from the Nasdaq Stock Market. The company is currently working towards meeting the criteria and is confident that it will regain compliance in the near future.
Price History
On Thursday, BIMI INTERNATIONAL MEDICAL failed to meet Nasdaq requirements, as its stock opened at $0.7 and closed at $0.7, a rise of 8.4% from its last closing price. The non-compliance with Nasdaq’s listing requirements will remain in effect until BIMI INTERNATIONAL MEDICAL regains compliance and fulfills the exchange’s other applicable continued listing requirements. In the meantime, BIMI INTERNATIONAL MEDICAL remains listed on Nasdaq Capital Market, but will be subject to additional monitoring. The company has stated that it is committed to taking action to regain compliance with the exchange’s listing criteria, but has yet to provide further details on how the company plans to do so. Investors should be aware that these measures might include share consolidation or an increase in share price.
In addition, the company may be subject to delisting if it does not successfully regain compliance with Nasdaq’s listing requirements. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for BIMI. More…
| Total Revenues | Net Income | Net Margin |
| 19.14 | -40.27 | -128.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for BIMI. More…
| Operations | Investing | Financing |
| -6.06 | 0.93 | 5.98 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for BIMI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 33 | 22.79 | 2.55 |
Key Ratios Snapshot
Some of the financial key ratios for BIMI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 48.5% | -59.0% | -207.9% |
| FCF Margin | ROE | ROA |
| -26.5% | -207.6% | -75.4% |
Analysis
At GoodWhale, we have conducted an analysis of BIMI INTERNATIONAL MEDICAL’s wellbeing. According to our Risk Rating, BIMI INTERNATIONAL MEDICAL is considered to be a medium risk investment in terms of financial and business aspects. However, our analysis has detected 3 risk warnings in the balance sheet, cashflow statement, and financial journal. If you would like to find out more about these risks, please register with us and we will be happy to provide you with more information. More…
Peers
SunLink Health Systems Inc, Kovai Medical Center & Hospital Ltd, and Yihua Healthcare Co Ltd are some of its competitors. BIMI offers a variety of services, including but not limited to, medical consultation, diagnostic services, and preventive care.
– SunLink Health Systems Inc ($NYSEAM:SSY)
SunLink Health Systems Inc is a company that provides healthcare services. It has a market capitalization of 6.42 million as of 2022 and a return on equity of -16.55%. The company has been in operation for over 10 years and provides services to patients in the United States.
– Kovai Medical Center & Hospital Ltd ($BSE:523323)
Kovai Medical Center & Hospital Ltd. is a healthcare provider based in India. The company operates hospitals, clinics, and diagnostic centers in Tamil Nadu, Kerala, and Karnataka. It also has a presence in Sri Lanka and the United Arab Emirates. The company offers a range of services including medical, surgical, and diagnostic services. It also has a pharmacy and a laboratory.
– Yihua Healthcare Co Ltd ($SZSE:000150)
Yihua Healthcare Co Ltd is a leading provider of healthcare services in China. The company operates a network of hospitals, clinics, and pharmacies across the country. It also provides health insurance products and services. Yihua Healthcare Co Ltd has a market cap of 1.11B as of 2022, a Return on Equity of 48.83%. The company is dedicated to providing quality healthcare services to its patients and is committed to improving the health and well-being of the communities it serves.
Summary
Investing in BIMI International Medical can be a risky endeavor. Despite this, its stock price moved up that same day. This could be considered a positive sign, as it indicates that the company’s fundamentals may still be strong despite the current non-compliance issue. It is important for investors to do their own research and evaluate the company’s financials before making any investment decisions. This includes looking at factors such as revenue, profit margins, debt levels, and cash flow.
Additionally, investors should take into consideration the risk factors associated with investing in a company that may not comply with Nasdaq listing requirements. It is always important to do your own due diligence before investing.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
